Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Versatile New Molecule-Building Technique
Tuesday, January 19, 2016
Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.

Shire to Combine with Baxalta
Tuesday, January 12, 2016
Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.

Using Nanoparticles to Combat Arteriosclerosis
Thursday, January 07, 2016
Researchers at the University of Bonn have developed a method for cell replacement in diseased vessels.

FDA Awards Breakthrough Therapy Designation to Boehringer’s Lung Cancer Candidate
Wednesday, January 06, 2016
Boehringer Ingelheim Pharmaceuticals has scored FDA breakthrough therapy designation for its candidate to treat patients with T790M mutation-positive non-small cell lung cancer.

Sanofi, Global Genomics Group Partner
Wednesday, January 06, 2016
Global Genomics Group ("G3") announced that it has entered into a research collaboration with Sanofi to identify new signaling pathways and targets involved in the etiology of coronary artery disease.

NIH-funded Memory Drug Moves into Phase 1 Clinical Study
Monday, January 04, 2016
Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition.

Hit Parade
Tuesday, December 22, 2015
Researchers are generating a list of compounds that may lead to a trio of new therapeutics.

RestorGenex, Diffusion Pharmaceuticals Announce Merger
Tuesday, December 22, 2015
Proposed merger would create an oncology-focused biotechnology company.

Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Tuesday, December 22, 2015
Halozyme Therapeutics, has announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE™ platform.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 4226
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!